Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia

Clinical trial NCT06858332 · RECRUITING

Trial details

NCT number: NCT06858332
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Atherosclerotic Cardiovascular Disease

Start date: 2025-04-15
Primary completion: 2027-09-30
Enrollment: 2382

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.